ENDRA Life Sciences Inc. (NDRA) Financials

NDRA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 3.4 million 1.7 million
Dec. 31, 2025 3.9 million 1.6 million
Sept. 30, 2025 2.0 million 1.8 million
June 30, 2025 2.8 million 1.3 million

NDRA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -1.1 million 574451
Dec. 31, 2025 -4.6 million 12878
Sept. 30, 2025 -1.2 million 144722
June 30, 2025 -1.1 million 88763

NDRA Net Income

No data available :(

NDRA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 356462 - 327253
Dec. 31, 2025 762365 - 362974
Sept. 30, 2025 794036 - 396537
June 30, 2025 1.8 million - 557492

NDRA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 1.2 million
Dec. 31, 2025 787020
Sept. 30, 2025 761218
June 30, 2025 717107

NDRA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 776410 1.4 million 4278
Dec. 31, 2025 3.0 million 508137 1.1 million 6360
Sept. 30, 2025 - 432113 938590 45285
June 30, 2025 - 381061 920029 68834

NDRA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 39715
Dec. 31, 2025 - 39532
Sept. 30, 2025 - 39389
June 30, 2025 - 32790

NDRA

Price: $4.23

52 week price:
2.96
11.96

Earnings Per Share: -8.16 USD

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 4700

Ebitda: -2.3 million

Market Capitalization: 3.6 million

Links: